MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Standard Scale for Syndrome Differentiation of Yin Deficiency Syndrome

Conditions
Yin Deficiency Syndrome
Interventions
Diagnostic Test: the diagnosis for Yin Deficiency Syndrome
First Posted Date
2021-03-19
Last Posted Date
2021-03-19
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
1200
Registration Number
NCT04806490
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

CDSS of Traditional Chinese Medicine Intervention for Dry Eye Syndrome

Not Applicable
Conditions
Dry Eye Syndromes
Interventions
Other: Routine intervention
Behavioral: Clinical Decision Support System
First Posted Date
2021-03-19
Last Posted Date
2021-03-19
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
120
Registration Number
NCT04806256
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

Risk Prediction Model of Preeclampsia

Conditions
Preeclampsia
Preeclampsia Severe
Interventions
Diagnostic Test: laboratory tests
First Posted Date
2021-03-12
Last Posted Date
2021-03-12
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
2000
Registration Number
NCT04794855
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Efficacy and Safety of Minimal Invasive Coronary Surgery in Patients With Complex Coronary Artery Lesions

Not Applicable
Conditions
Coronary Artery Bypass, Off-Pump
Interventions
Procedure: Minimal invasive coronary surgery
Procedure: Off-pump coronary artery bypass surgery
First Posted Date
2021-03-12
Last Posted Date
2021-03-12
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
200
Registration Number
NCT04795193
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion

Conditions
Lumbar Spine Degeneration
First Posted Date
2021-03-04
Last Posted Date
2022-02-09
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
400
Registration Number
NCT04781517
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid

Phase 4
Not yet recruiting
Conditions
Postmenopausal Osteoporosis
Interventions
First Posted Date
2021-01-22
Last Posted Date
2021-06-23
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
64
Registration Number
NCT04719650

Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Phase 4
Conditions
Postmenopausal Osteoporosis
Interventions
First Posted Date
2021-01-22
Last Posted Date
2021-06-23
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
110
Registration Number
NCT04719481

A Randomized Controlled Trial for Patients Underwent Total Hip Arthroplasties Assisted by Surgical Navigation System

Not Applicable
Conditions
Hip Arthropathy
Interventions
Device: "VTS" surgical navigation system
First Posted Date
2021-01-15
Last Posted Date
2021-01-29
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
124
Registration Number
NCT04711720

Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in AECOPD

Conditions
COPD Exacerbation Acute
COPD
Interventions
Diagnostic Test: Serum metabolic markers
First Posted Date
2021-01-15
Last Posted Date
2021-01-15
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
100
Registration Number
NCT04710849
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

Conditions
Recurrent Rectal Cancer
125I Seeds Implantation
Clinical Target Volume
Interventions
Radiation: CTV
First Posted Date
2021-01-14
Last Posted Date
2021-01-14
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
60
Registration Number
NCT04710589
Locations
🇨🇳

Peking Unnversity Third Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath